JP2020526206A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020526206A5 JP2020526206A5 JP2020500887A JP2020500887A JP2020526206A5 JP 2020526206 A5 JP2020526206 A5 JP 2020526206A5 JP 2020500887 A JP2020500887 A JP 2020500887A JP 2020500887 A JP2020500887 A JP 2020500887A JP 2020526206 A5 JP2020526206 A5 JP 2020526206A5
- Authority
- JP
- Japan
- Prior art keywords
- cgamp
- sample
- test
- cells
- test compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762530661P | 2017-07-10 | 2017-07-10 | |
| US62/530,661 | 2017-07-10 | ||
| PCT/US2018/041480 WO2019014246A1 (en) | 2017-07-10 | 2018-07-10 | TARGETING CHROMOSOMIC INSTABILITY AND SIGNALING OF CYTOSOLIC DNA IN AVAL FOR THE TREATMENT OF CANCER |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020526206A JP2020526206A (ja) | 2020-08-31 |
| JP2020526206A5 true JP2020526206A5 (https=) | 2022-08-18 |
| JP7197556B2 JP7197556B2 (ja) | 2022-12-27 |
Family
ID=63036469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020500887A Active JP7197556B2 (ja) | 2017-07-10 | 2018-07-10 | がん治療のための染色体不安定性および下流サイトゾルｄｎａシグナル伝達をターゲティングする方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11821042B2 (https=) |
| EP (1) | EP3652349A1 (https=) |
| JP (1) | JP7197556B2 (https=) |
| KR (1) | KR20200037796A (https=) |
| CN (1) | CN111295454A (https=) |
| AU (1) | AU2018300007A1 (https=) |
| BR (1) | BR112020000477A2 (https=) |
| CA (1) | CA3069515A1 (https=) |
| IL (1) | IL271849A (https=) |
| MX (1) | MX2020000406A (https=) |
| SG (1) | SG11202000132WA (https=) |
| WO (1) | WO2019014246A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018045155A1 (en) * | 2016-09-02 | 2018-03-08 | The Board Of Trustees Of The University Of Illinois | Kif13b-derived peptide and method of inhibiting angiogenesis |
| AU2018300007A1 (en) | 2017-07-10 | 2020-02-27 | Cornell University | Targeting chromosomal instability and downstream cytosolic DNA signaling for cancer treatment |
| JP7226763B2 (ja) * | 2017-08-17 | 2023-02-21 | 国立大学法人山口大学 | 癌幹細胞における薬物耐性の低減剤、癌幹細胞における転移能の抑制剤及び癌の転移性再発リスクを予測する方法 |
| CN114761804A (zh) * | 2019-06-21 | 2022-07-15 | 艾福姆德尤股份有限公司 | 治疗癌症的方法 |
| US20230346785A1 (en) * | 2020-02-19 | 2023-11-02 | Ibmc - Instituto De Biologia Molecular E Celular | 4-PYRROLIDIN-1-Yl-5-P-TOLYL-THIENO[2,3-D] PYRIMIDINE FOR USE IN THE TREATMENT OF AGING-ASSOCIATED AND PREMATURE AGING DISEASES THROUGH RESTORED CHROMOSOMAL STABILITY AND INHIBITION OF CELLULAR SENESCENCE |
| JP2023534375A (ja) * | 2020-05-28 | 2023-08-09 | 王 道祥 | 細胞病理学的サンプルに対する多重染色切片調製法 |
| AU2021336887A1 (en) * | 2020-09-02 | 2023-03-30 | Memorial Sloan Kettering Cancer Center | Methods and compositions for targeting cytosolic dsDNA signaling in chromosomally unstable cancers |
| US20240207248A1 (en) * | 2021-04-23 | 2024-06-27 | Baruch S. Blumberg Institute | Methods, kits and compositions for reducing chromosomal instability in cancer cells |
| CN113341154B (zh) * | 2021-05-14 | 2024-11-05 | 医工瑞思(福建)工程研究中心有限公司 | 一种检测血栓或凝血相关疾病的生物标志物及其应用 |
| IL310863A (en) | 2021-08-26 | 2024-04-01 | Volastra Therapeutics Inc | Spiro indoline inhibitors of kif18a |
| CN115354078B (zh) * | 2022-09-02 | 2023-07-07 | 中山大学附属第一医院 | 骨肉瘤检测标记物及其应用 |
| EP4488389A1 (en) * | 2023-07-05 | 2025-01-08 | Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) | Signature for the prognosis of brain metastasis relapse |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4962091A (en) | 1986-05-23 | 1990-10-09 | Syntex (U.S.A.) Inc. | Controlled release of macromolecular polypeptides |
| WO1994007529A1 (en) | 1992-09-25 | 1994-04-14 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6306434B1 (en) | 1997-02-12 | 2001-10-23 | Chong Kun Dang Corp. | Pharmaceutical composition comprising cyclosporin solid-state microemulsion |
| GB201121070D0 (en) | 2011-12-07 | 2012-01-18 | Isis Innovation | composition for delivery of biotherapeutics |
| EP2934598B1 (en) | 2012-12-19 | 2018-04-18 | Board Of Regents, The University Of Texas System | Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway |
| WO2015036643A2 (es) | 2013-09-13 | 2015-03-19 | Sierra Jiménez Angels | Marcador para predecir metástasis del cancer de mama |
| BR112016020897A2 (en) * | 2014-03-11 | 2018-01-23 | The Council Of The Queensland Institute Of Medical Research | Determination of cancer aggressiveness, prognosis, and responsiveness to treatment |
| JP6898848B2 (ja) * | 2014-09-19 | 2021-07-07 | メモリアル スローン ケタリング キャンサー センター | 脳転移を治療するための方法 |
| WO2016176222A1 (en) | 2015-04-30 | 2016-11-03 | University Of Washington | Cgas in systemic lupus erythematosus (sle) |
| AU2018300007A1 (en) | 2017-07-10 | 2020-02-27 | Cornell University | Targeting chromosomal instability and downstream cytosolic DNA signaling for cancer treatment |
-
2018
- 2018-07-10 AU AU2018300007A patent/AU2018300007A1/en not_active Abandoned
- 2018-07-10 KR KR1020207003861A patent/KR20200037796A/ko not_active Withdrawn
- 2018-07-10 MX MX2020000406A patent/MX2020000406A/es unknown
- 2018-07-10 EP EP18746496.1A patent/EP3652349A1/en active Pending
- 2018-07-10 US US16/629,512 patent/US11821042B2/en active Active
- 2018-07-10 SG SG11202000132WA patent/SG11202000132WA/en unknown
- 2018-07-10 CA CA3069515A patent/CA3069515A1/en active Pending
- 2018-07-10 WO PCT/US2018/041480 patent/WO2019014246A1/en not_active Ceased
- 2018-07-10 BR BR112020000477-4A patent/BR112020000477A2/pt not_active Application Discontinuation
- 2018-07-10 CN CN201880058523.8A patent/CN111295454A/zh active Pending
- 2018-07-10 JP JP2020500887A patent/JP7197556B2/ja active Active
-
2020
- 2020-01-06 IL IL271849A patent/IL271849A/en unknown
-
2023
- 2023-04-12 US US18/299,558 patent/US20240110246A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020526206A5 (https=) | ||
| Park et al. | Yes‐associated protein 1 and transcriptional coactivator with PDZ‐binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma | |
| US11447831B2 (en) | Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonists | |
| US20190192517A1 (en) | Treatment of squamous cell carcinomas with inhibitors of erk | |
| JP2020198883A (ja) | 癌の分類および使用法 | |
| CN103382503B (zh) | Egfr基因19号外显子19种缺失突变检测试剂盒及检测方法 | |
| Lee et al. | Profiling of protein–protein interactions via single-molecule techniques predicts the dependence of cancers on growth-factor receptors | |
| CN112494467A (zh) | 香兰素在制备尼克酰胺-n-甲基转移酶抑制剂中的应用 | |
| Decker et al. | Adrenergic blockade promotes maintenance of dormancy in prostate cancer through upregulation of GAS6 | |
| KR20220123064A (ko) | Cdk12/13 억제제에 의한 암 치료 | |
| WO2012112245A1 (en) | Modulation of phosphatidylinositol-5-phosphate-4-kinase activity | |
| CA2840129A1 (en) | Method for predicting the clinical response to chemotherapy in a subject with cancer | |
| JP7383282B2 (ja) | 非アルコール性脂肪肝炎マーカー及びその利用 | |
| US20130004424A1 (en) | Methods for determining agents targeting mena isoforms and uses thereof for diagnosis and treatment of metastatic tumors | |
| JP2014137282A (ja) | うつ病マーカー、アッセイ方法、うつ病決定方法、うつ病薬のスクリーニング方法及びキット | |
| CN109554469A (zh) | T细胞急性淋巴性白血病的肿瘤细胞及其分子标志 | |
| KR102132222B1 (ko) | 항암제 내성 진단 마커로서의 miR-143-3p 및 miR-373-5p, 및 이의 이용 | |
| Ha et al. | Lipidomic analysis of glioblastoma multiforme using mass spectrometry | |
| Du et al. | A novel break site of EML4‐ALK report and a rare PRKAR1A‐ALK report analyzed by different ALK detection platforms in non‐small cell lung cancer patients | |
| JPWO2012002274A1 (ja) | 培養細胞を用いたｓ１ｐリアーゼ阻害剤のスクリーニング方法 | |
| WO2012130720A2 (en) | PREDICTION OF RESPONSIVENESS TO PIK3/mTOR INHIBITORS | |
| US20230341404A1 (en) | Targeting stroma-cancer interactions in cancer | |
| Hao et al. | Discovery of anti-tumor small molecule lead compounds targeting the SH3 domain of c-Src protein through virtual screening and biological evaluation | |
| CN115887657A (zh) | Jak2/stat3抑制剂单独或联合卡铂在制备乳腺癌治疗药物中的应用 | |
| Meggs et al. | Re-expression of α skeletal actin and regulation of α1 adrenoceptor signalling in DOCA-salt hypertension in rats |